Literature review on the immunogenicity of herpes zoster vaccines . : HP40-243/2018E-PDF
"Herpes zoster is an acute viral infection caused by reactivation of varicella-zoster virus (VZV). LZV, a live, attenuated vaccine for zoster has been available in Canada for many years. A new subunit recombinant zoster vaccine (RZV) named Shingrix was approved in Canada in October 2017. This zoster vaccine immunogenicity review was done to have a comprehensive understanding of the immunogenicity of both live and subunit vaccines"--Executive summary, p. 3.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.865656&sl=1
Ministère/Organisme | Public Health Agency of Canada. |
---|---|
Titre | Literature review on the immunogenicity of herpes zoster vaccines . |
Type de publication | Monographie |
Langue | [Anglais] |
Autres langues publiées | [Français] |
Format | Électronique |
Document électronique | |
Note(s) | Issued also in French under title: Revue de la littérature sur l'immunogénicité des vaccins contre le zona. "Publication date: January 2019." "An Advisory Committee Review (ACR), National Advisory Committee on Immunization (NACI)." Cover title. Includes bibliographical references. |
Information sur la publication | [Ottawa] : Public Health Agency of Canada, 2019. |
Description | 46 p. |
ISBN | 9780660288628 |
Numéro de catalogue |
|
Numéro de catalogue du ministère | Pub. : 180582 |
Descripteurs | Immunization |